{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:29:47Z","timestamp":1793892587233,"version":"4.8.0"},"reference-count":59,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2024,8,1]]},"abstract":"<jats:sec id=\"ab-noi240035-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Sleep disturbances are common among older adults and have been associated with the development of Alzheimer disease (AD), such as amyloid-\u03b2 (A\u03b2) pathology. For effective AD prevention, it is essential to pinpoint the specific disturbances in sleep and the underlying 24-hour activity rhythms that confer the highest risk of A\u03b2 deposition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi240035-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      To determine the associations of 24-hour activity rhythms and sleep with A\u03b2 deposition in adults without dementia, to evaluate whether disrupted 24-hour activity and sleep may precede A\u03b2 deposition, and to assess the role of the apolipoprotein E \u03b54 (\n                      <jats:italic>APOE4<\/jats:italic>\n                      ) genotype.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi240035-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>\n                      This was an observational cohort study using data from the Rotterdam Study. Of 639 participants without dementia who underwent A\u03b2 positron emission tomography (PET) from September 2018 to November 2021, 319 were included in the current study. Exclusion criteria were no\n                      <jats:italic>APOE<\/jats:italic>\n                      genotyping and no valid actigraphy data at the baseline visits from 2004 to 2006 or from 2012 to 2014. The mean (SD) follow-up was 7.8 (2.4) years. Data were analyzed from March 2023 to April 2024.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi240035-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>\n                      Actigraphy (7 days and nights, objective sleep, and 24-hour activity rhythms), sleep diaries (self-reported sleep), A\u03b242\/40, phosphorylated tau (p-tau)\n                      <jats:sub>181<\/jats:sub>\n                      and p-tau\n                      <jats:sub>217<\/jats:sub>\n                      plasma assays,\n                      <jats:sup>18<\/jats:sup>\n                      F-florbetaben PET (mean standard uptake value ratio [SUVR] in a large cortical region of interest), and\n                      <jats:italic>APOE4<\/jats:italic>\n                      genotype.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi240035-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Association of objective and self-reported sleep and 24-hour activity rhythms at baseline with brain A\u03b2 PET burden at follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi240035-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The mean (range) age in the study population was 61.5 (48-80) years at baseline and 69.2 (60-88) years at follow-up; 150 (47%) were women. Higher intradaily variability at baseline, an indicator of fragmented 24-hour activity rhythms, was associated with higher A\u03b2 PET burden at follow-up (\u03b2, 0.15; bootstrapped 95% CI, 0.04 to 0.26; bootstrapped\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.02, false discovery rate [FDR]\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.048).\n                      <jats:italic>APOE<\/jats:italic>\n                      genotype modified this association, which was stronger in\n                      <jats:italic>APOE4<\/jats:italic>\n                      carriers (\u03b2, 0.38; bootstrapped 95% CI, 0.05 to 0.64; bootstrapped\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.03) compared to noncarriers (\u03b2, 0.07; bootstrapped 95% CI, \u22120.04 to 0.18; bootstrapped\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.19). The findings remained largely similar after excluding participants with AD pathology at baseline, suggesting that a fragmented 24-hour activity rhythm may have preceded A\u03b2 deposition. No other objective or self-reported measure of sleep was associated with A\u03b2.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi240035-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>\n                      Among community-dwelling adults included in this study, higher fragmentation of the 24-hour activity rhythms was associated with greater subsequent A\u03b2 burden, especially in\n                      <jats:italic>APOE4<\/jats:italic>\n                      carriers. These results suggest that rest-activity fragmentation could represent a modifiable risk factor for AD.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaneurol.2024.1755","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T11:00:41Z","timestamp":1719226841000},"page":"824","source":"Crossref","is-referenced-by-count":66,"title":["Sleep, 24-Hour Activity Rhythms, and Subsequent Amyloid-\u03b2 Pathology"],"prefix":"10.1001","volume":"81","author":[{"given":"Phuong Thuy","family":"Nguyen Ho","sequence":"first","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Erasmus University Medical Centre, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne J. W.","family":"Hoepel","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Erasmus University Medical Centre, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Rodriguez-Ayllon","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Erasmus University Medical Centre, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie I.","family":"Luik","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Erasmus University Medical Centre, Rotterdam, the Netherlands"},{"name":"Trimbos Institute\u2014the Netherlands Institute of Mental Health and Addiction, Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meike W.","family":"Vernooij","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Erasmus University Medical Centre, Rotterdam, the Netherlands"},{"name":"Department of Epidemiology, Erasmus University Medical Centre, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Neitzel","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Erasmus University Medical Centre, Rotterdam, the Netherlands"},{"name":"Department of Epidemiology, Erasmus University Medical Centre, Rotterdam, the Netherlands"},{"name":"Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"noi240035r1","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1001\/jamaneurol.2022.0976","article-title":"Risk factors associated with alzheimer disease and related dementias by sex and race and ethnicity in the US.","volume":"79","author":"Nianogo","year":"2022","journal-title":"JAMA Neurol"},{"issue":"10248","key":"noi240035r2","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet"},{"issue":"7","key":"noi240035r3","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.5665\/sleep.2802","article-title":"Sleep fragmentation and the risk of incident Alzheimer\u2019s disease and cognitive decline in older persons.","volume":"36","author":"Lim","year":"2013","journal-title":"Sleep"},{"key":"noi240035r4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.smrv.2017.06.010","article-title":"Sleep disturbances increase the risk of dementia: a systematic review and meta-analysis.","volume":"40","author":"Shi","year":"2018","journal-title":"Sleep Med Rev"},{"issue":"5","key":"noi240035r5","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/ana.v70.5","article-title":"Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women.","volume":"70","author":"Tranah","year":"2011","journal-title":"Ann Neurol"},{"key":"noi240035r6","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101046","article-title":"Circadian and sleep dysfunction in Alzheimer\u2019s disease.","volume":"60","author":"Uddin","year":"2020","journal-title":"Ageing Res Rev"},{"issue":"3","key":"noi240035r7","doi-asserted-by":"publisher","first-page":"e148","DOI":"10.1038\/emm.2014.121","article-title":"Sleep, circadian rhythms, and the pathogenesis of Alzheimer disease.","volume":"47","author":"Musiek","year":"2015","journal-title":"Exp Mol Med"},{"issue":"5955","key":"noi240035r8","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1126\/science.1180962","article-title":"Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle.","volume":"326","author":"Kang","year":"2009","journal-title":"Science"},{"issue":"6156","key":"noi240035r9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1126\/science.1241224","article-title":"Sleep drives metabolite clearance from the adult brain.","volume":"342","author":"Xie","year":"2013","journal-title":"Science"},{"issue":"12","key":"noi240035r10","doi-asserted-by":"publisher","first-page":"5506","DOI":"10.1002\/alz.v19.12","article-title":"Predicting amyloid-beta pathology in the general population.","volume":"19","author":"Nguyen Ho","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"7","key":"noi240035r11","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.17573","article-title":"Association of sleep and \u00df-amyloid pathology among older cognitively unimpaired adults.","volume":"4","author":"Insel","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"10","key":"noi240035r12","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1001\/jamaneurol.2021.2876","article-title":"Association of short and long sleep duration with amyloid-\u00df burden and cognition in aging.","volume":"78","author":"Winer","year":"2021","journal-title":"JAMA Neurol"},{"issue":"12","key":"noi240035r13","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1001\/jamaneurol.2013.4258","article-title":"Self-reported sleep and \u00df-amyloid deposition in community-dwelling older adults.","volume":"70","author":"Spira","year":"2013","journal-title":"JAMA Neurol"},{"issue":"8","key":"noi240035r14","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1002\/alz.v16.8","article-title":"Sleep characteristics and cerebrospinal fluid biomarkers of Alzheimer\u2019s disease pathology in cognitively intact older adults: the CABLE study.","volume":"16","author":"Xu","year":"2020","journal-title":"Alzheimers Dement"},{"issue":"9","key":"noi240035r15","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1016\/j.neurobiolaging.2015.05.004","article-title":"Amyloid burden is associated with self-reported sleep in nondemented late middle-aged adults.","volume":"36","author":"Sprecher","year":"2015","journal-title":"Neurobiol Aging"},{"issue":"13","key":"noi240035r16","doi-asserted-by":"publisher","first-page":"e1167","DOI":"10.1212\/WNL.0000000000005193","article-title":"Moderating effect of APOE e4 on the relationship between sleep-wake cycle and brain \u00df-amyloid.","volume":"90","author":"Hwang","year":"2018","journal-title":"Neurology"},{"issue":"5","key":"noi240035r17","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1001\/jamaneurol.2013.2334","article-title":"Sleep quality and preclinical Alzheimer disease.","volume":"70","author":"Ju","year":"2013","journal-title":"JAMA Neurol"},{"issue":"9","key":"noi240035r18","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsz137","article-title":"Relationships between objectives sleep parameters and brain amyloid load in subjects at risk for Alzheimer\u2019s disease: the INSIGHT-preAD Study.","volume":"42","author":"Ettore","year":"2019","journal-title":"Sleep"},{"key":"noi240035r19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.neurobiolaging.2016.02.009","article-title":"Relationships between sleep quality and brain volume, metabolism, and amyloid deposition in late adulthood.","volume":"41","author":"Branger","year":"2016","journal-title":"Neurobiol Aging"},{"issue":"5","key":"noi240035r20","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.5665\/sleep.5756","article-title":"The relationship between sleep quality and brain amyloid burden.","volume":"39","author":"Brown","year":"2016","journal-title":"Sleep"},{"issue":"6","key":"noi240035r21","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1001\/jamaneurol.2018.0049","article-title":"Association of excessive daytime sleepiness with longitudinal \u00df-amyloid accumulation in elderly persons without dementia.","volume":"75","author":"Carvalho","year":"2018","journal-title":"JAMA Neurol"},{"issue":"1","key":"noi240035r22","doi-asserted-by":"publisher","DOI":"10.1093\/sleepadvances\/zpab015","article-title":"Brain amyloid burden, sleep, and 24-hour rest\/activity rhythms: screening findings from the Anti-Amyloid Treatment in Asymptomatic Alzheimer\u2019s and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration Studies.","volume":"2","author":"Spira","year":"2021","journal-title":"Sleep Adv"},{"issue":"3","key":"noi240035r23","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/sleep\/26.3.342","article-title":"The role of actigraphy in the study of sleep and circadian rhythms.","volume":"26","author":"Ancoli-Israel","year":"2003","journal-title":"Sleep"},{"issue":"5","key":"noi240035r24","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1001\/jamaneurol.2017.4719","article-title":"Circadian rest-activity pattern changes in aging and preclinical Alzheimer disease.","volume":"75","author":"Musiek","year":"2018","journal-title":"JAMA Neurol"},{"key":"noi240035r25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.smrv.2014.03.007","article-title":"Sleep and Alzheimer\u2019s disease.","volume":"19","author":"Peter-Derex","year":"2015","journal-title":"Sleep Med Rev"},{"issue":"JUN","key":"noi240035r26","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3389\/fphar.2019.00695","article-title":"Sleep and \u00df-amyloid deposition in Alzheimer disease: Insights on mechanisms and possible innovative treatments.","volume":"10","author":"Cordone","year":"2019","journal-title":"Front Pharmacol"},{"issue":"2","key":"noi240035r27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrneurol.2013.269","article-title":"Sleep and Alzheimer disease pathology\u2013a bidirectional relationship.","volume":"10","author":"Ju","year":"2014","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"noi240035r28","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41386-019-0478-5","article-title":"Bidirectional relationship between sleep and Alzheimer\u2019s disease: role of amyloid, tau, and other factors.","volume":"45","author":"Wang","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"noi240035r29","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41380-018-0246-7","article-title":"Genome-wide association study of brain amyloid deposition as measured by Pittsburgh Compound-B (PiB)-PET imaging.","volume":"26","author":"Yan","year":"2021","journal-title":"Mol Psychiatry"},{"issue":"14","key":"noi240035r30","doi-asserted-by":"publisher","DOI":"10.1172\/JCI169131","article-title":"APOE-e4 synergizes with sleep disruption to accelerate A\u00df deposition and A\u00df-associated tau seeding and spreading.","volume":"133","author":"Wang","year":"2023","journal-title":"J Clin Invest"},{"issue":"5","key":"noi240035r31","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s10654-020-00640-5","article-title":"Objectives, design and main findings until 2020 from the Rotterdam Study.","volume":"35","author":"Ikram","year":"2020","journal-title":"Eur J Epidemiol"},{"issue":"12","key":"noi240035r32","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s10654-015-0105-7","article-title":"The Rotterdam scan study: design update 2016 and main findings.","volume":"30","author":"Ikram","year":"2015","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"noi240035r33","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/brain\/awac354","article-title":"Diabetes and hypertension are related to amyloid-beta burden in the population-based Rotterdam Study.","volume":"146","author":"van Arendonk","year":"2023","journal-title":"Brain"},{"issue":"5","key":"noi240035r34","doi-asserted-by":"publisher","first-page":"781","DOI":"10.5665\/sleep.2648","article-title":"Sleep estimates using microelectromechanical systems (MEMS).","volume":"36","author":"te Lindert","year":"2013","journal-title":"Sleep"},{"issue":"5","key":"noi240035r35","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S1389-9457(00)00098-8","article-title":"Comparison of actigraphic, polysomnographic, and subjective assessment of sleep parameters in sleep-disordered patients.","volume":"2","author":"Kushida","year":"2001","journal-title":"Sleep Med"},{"issue":"4","key":"noi240035r36","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0006-3223(95)00370-3","article-title":"Circadian rest-activity rhythm disturbances in Alzheimer\u2019s disease.","volume":"40","author":"van Someren","year":"1996","journal-title":"Biol Psychiatry"},{"issue":"1","key":"noi240035r37","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1093\/aje\/kwu245","article-title":"Fragmentation and stability of circadian activity rhythms predict mortality: the Rotterdam Study.","volume":"181","author":"Zuurbier","year":"2015","journal-title":"Am J Epidemiol"},{"issue":"10","key":"noi240035r38","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3109\/07420528.2013.813528","article-title":"Stability and fragmentation of the activity rhythm across the sleep-wake cycle: the importance of age, lifestyle, and mental health.","volume":"30","author":"Luik","year":"2013","journal-title":"Chronobiol Int"},{"issue":"1","key":"noi240035r39","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3233\/JAD-180055","article-title":"Subjective sleep quality is not associated with incident dementia: the Rotterdam Study.","volume":"64","author":"Lysen","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"noi240035r40","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S1474-4422(08)70001-2","article-title":"Imaging of amyloid \u00df in Alzheimer\u2019s disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism.","volume":"7","author":"Rowe","year":"2008","journal-title":"Lancet Neurol"},{"issue":"1","key":"noi240035r41","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.sleh.2014.12.010","article-title":"National Sleep Foundation\u2019s sleep time duration recommendations: methodology and results summary.","volume":"1","author":"Hirshkowitz","year":"2015","journal-title":"Sleep Health"},{"issue":"3","key":"noi240035r42","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","article-title":"Diagnostic accuracy of a plasma phosphorylated tau 217 immunoassay for Alzheimer disease pathology.","volume":"81","author":"Ashton","year":"2024","journal-title":"JAMA Neurol"},{"issue":"9","key":"noi240035r43","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1093\/brain\/awab163","article-title":"Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjects.","volume":"144","author":"Pereira","year":"2021","journal-title":"Brain"},{"issue":"5","key":"noi240035r44","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202217123","article-title":"Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads.","volume":"15","author":"Salvad\u00f3","year":"2023","journal-title":"EMBO Mol Med"},{"issue":"1","key":"noi240035r45","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1001\/jamaneurol.2023.4596","article-title":"Plasma biomarker strategy for selecting patients with Alzheimer disease for antiamyloid immunotherapies.","volume":"81","author":"Mattsson-Carlgren","year":"2024","journal-title":"JAMA Neurol"},{"issue":"9","key":"noi240035r46","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/alz.v16.9","article-title":"Actigraphy-estimated sleep and 24-hour activity rhythms and the risk of dementia.","volume":"16","author":"Lysen","year":"2020","journal-title":"Alzheimers Dement"},{"issue":"8","key":"noi240035r47","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/mp.2012.162","article-title":"Multiple effects of physical activity on molecular and cognitive signs of brain aging: can exercise slow neurodegeneration and delay Alzheimer\u2019s disease?","volume":"18","author":"Brown","year":"2013","journal-title":"Mol Psychiatry"},{"issue":"6","key":"noi240035r48","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1097\/EDE.0b013e318187a7b0","article-title":"Self-reported and measured sleep duration: how similar are they?","volume":"19","author":"Lauderdale","year":"2008","journal-title":"Epidemiology"},{"issue":"1","key":"noi240035r49","doi-asserted-by":"publisher","first-page":"9","DOI":"10.5665\/sleep.3298","article-title":"Sleep health: can we define it? does it matter?","volume":"37","author":"Buysse","year":"2014","journal-title":"Sleep"},{"issue":"1","key":"noi240035r50","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13195-019-0536-6","article-title":"Sleep experiences during different lifetime periods and in vivo Alzheimer pathologies.","volume":"11","author":"Choe","year":"2019","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"noi240035r51","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.neuron.2019.01.056","article-title":"A quarter century of APOE and Alzheimer\u2019s disease: progress to date and the path forward.","volume":"101","author":"Belloy","year":"2019","journal-title":"Neuron"},{"issue":"150","key":"noi240035r52","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3004291","article-title":"Disruption of the sleep-wake cycle and diurnal fluctuation of \u00df-amyloid in mice with Alzheimer\u2019s disease pathology.","volume":"4","author":"Roh","year":"2012","journal-title":"Sci Transl Med"},{"issue":"8","key":"noi240035r53","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1001\/jamaneurol.2014.1173","article-title":"Effect of 1 night of total sleep deprivation on cerebrospinal fluid \u00df-amyloid 42 in healthy middle-aged men: a randomized clinical trial.","volume":"71","author":"Ooms","year":"2014","journal-title":"JAMA Neurol"},{"issue":"147","key":"noi240035r54","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3003748","article-title":"A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u00df.","volume":"4","author":"Iliff","year":"2012","journal-title":"Sci Transl Med"},{"issue":"6465","key":"noi240035r55","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1126\/science.aax5440","article-title":"Coupled electrophysiological, hemodynamic, and cerebrospinal fluid oscillations in human sleep.","volume":"366","author":"Fultz","year":"2019","journal-title":"Science"},{"key":"noi240035r56","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.nbd.2016.05.015","article-title":"Suppression of glymphatic fluid transport in a mouse model of Alzheimer\u2019s disease.","volume":"93","author":"Peng","year":"2016","journal-title":"Neurobiol Dis"},{"issue":"6","key":"noi240035r57","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsy057","article-title":"Agreement between self-reported and objectively measured sleep duration among white, black, Hispanic, and Chinese adults in the United States: Multi-Ethnic Study of Atherosclerosis.","volume":"41","author":"Jackson","year":"2018","journal-title":"Sleep"},{"issue":"7","key":"noi240035r58","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1164\/rccm.201704-0704OC","article-title":"Obstructive sleep apnea severity affects amyloid burden in cognitively normal elderly. a longitudinal study.","volume":"197","author":"Sharma","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"noi240035r59","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/ana.v85.2","article-title":"Obstructive sleep apnea treatment, slow wave activity, and amyloid-\u00df.","volume":"85","author":"Ju","year":"2019","journal-title":"Ann Neurol"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2820395\/jamaneurology_nguyen_ho_2024_oi_240035_1723221544.44987.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T11:01:21Z","timestamp":1723460481000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2820395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":59,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2024.1755","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,1]]}}}